These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31125042)

  • 21. [Ketamine--a new treatment option for therapy-resistant depression].
    Köhler S; Betzler F
    Fortschr Neurol Psychiatr; 2015 Feb; 83(2):91-7. PubMed ID: 25723773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ketamine for treatment of acute depression].
    Hjerrild S; Bjerre J; Pedersen RH; Videbech P
    Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
    Downey D; Dutta A; McKie S; Dawson GR; Dourish CT; Craig K; Smith MA; McCarthy DJ; Harmer CJ; Goodwin GM; Williams S; Deakin JF
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):994-1003. PubMed ID: 27133029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant effects of ketamine in depressed patients.
    Berman RM; Cappiello A; Anand A; Oren DA; Heninger GR; Charney DS; Krystal JH
    Biol Psychiatry; 2000 Feb; 47(4):351-4. PubMed ID: 10686270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketamine followed by memantine for the treatment of major depression.
    Kollmar R; Markovic K; Thürauf N; Schmitt H; Kornhuber J
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514
    [No Abstract]   [Full Text] [Related]  

  • 26. Ketamine as an antidepresessant: a brief research history.
    Wanderer JP; Rathmell JP
    Anesthesiology; 2014 Jul; 121(1):A29. PubMed ID: 24936933
    [No Abstract]   [Full Text] [Related]  

  • 27. Ketamine and Electroconvulsive Therapy for Depression.
    Andrade C
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):288-289. PubMed ID: 30001277
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage.
    Scheele D; Zimbal S; Feinstein JS; Delis A; Neumann C; Mielacher C; Philipsen A; Hurlemann R
    Am J Psychiatry; 2019 Dec; 176(12):982-986. PubMed ID: 31787017
    [No Abstract]   [Full Text] [Related]  

  • 29. Scientific Issues Relevant to Improving the Diagnosis, Risk Assessment, and Treatment of Major Depression.
    Schatzberg AF
    Am J Psychiatry; 2019 May; 176(5):342-347. PubMed ID: 31039643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of mTOR in depression and antidepressant responses.
    Abelaira HM; Réus GZ; Neotti MV; Quevedo J
    Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ketamine in acute and severe major depressive disorder].
    Brittner M; Micoulaud-Franchi JA; Richieri R; Boyer L; Adida M; Lancon C; Fond G
    Presse Med; 2014 May; 43(5):492-500. PubMed ID: 24630265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental medication treatment approaches for depression.
    Ionescu DF; Papakostas GI
    Transl Psychiatry; 2017 Mar; 7(3):e1068. PubMed ID: 28323287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of copper and ketamine in major depressive disorder - an update.
    Słupski J; Słupska A; Szałach ŁP; Włodarczyk A; Górska N; Szarmach J; Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wilkowska A; Wiglusz MS; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):520-523. PubMed ID: 31488784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New perspectives on glutamate receptor antagonists as antidepressants.
    Chung C
    Arch Pharm Res; 2012 Mar; 35(4):573-7. PubMed ID: 22553049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
    Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of ketamine as an antidepressant: a systematic review and meta-analysis.
    Coyle CM; Laws KR
    Hum Psychopharmacol; 2015 May; 30(3):152-63. PubMed ID: 25847818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMDA antagonist treatment of depression.
    Williams NR; Schatzberg AF
    Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal ketamine treatment in an adult with autism spectrum disorder.
    Wink LK; O'Melia AM; Shaffer RC; Pedapati E; Friedmann K; Schaefer T; Erickson CA
    J Clin Psychiatry; 2014 Aug; 75(8):835-6. PubMed ID: 25191906
    [No Abstract]   [Full Text] [Related]  

  • 40. Reducing the silence.
    Nat Med; 2016 Oct; 22(10):1063. PubMed ID: 27711062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.